Clinical and genetic spectrum of an orphan disease MPAN: a series with new variants and a novel phenotype
, 2, 2, 3, 4, 5, 6, 2, 7
Abstract
Introduction. Pathogenic variations in C19orf12 are responsible for two allelic diseases: mitochondrial membrane protein-associated neurodegeneration (MPAN); and spastic paraplegia type 43 (SPG43). MPAN is an orphan disease, which presents with spasticity, dystonia, peripheral nerve involvement, and dementia. The pattern of iron accumulation on brain MRI may be a clue for the diagnosis of MPAN. SPG43, on the other hand, is characterised by progressive lower limb spasticity without brain iron accumulation. We here present clinical and genetic findings of MPAN patients with potentially pathogenic C19orf12 variants.
Materials and methods. Patients from 13 different families having progressive motor symptoms with irritative pyramidal signs and brain iron accumulation were screened for C19orf12 gene variants.
Results. C19orf12 screening identified seven variants associated with MPAN in eight patients from seven families. We associated two pathogenic variants (c.24G > C; p.(Lys8Asn) and c.194G > A; p.(Gly65Glu)) with the MPAN phenotype for the first time. We also provided a genetic diagnosis for a patient with an atypical MPAN presentation. The variant c.32C > T; p.(Thr11Met), common to Turkish adult-onset MPAN patients, was also detected in two unrelated late-onset MPAN patients.
Conclusions. Genetic analysis along with thorough clinical analysis supported by radiological findings will aid the differential diagnosis of MPAN within the neurodegeneration with brain iron accumulation spectrum as well as other disorders including hereditary spastic paraplegia. Dystonia and parkinsonism may not be the leading clinical findings in MPAN patients, as these are absent in the atypical case. Finally, we emphasise that the existence of frameshifting variants may bias the age of onset toward childhood.
Keywords: MPANC19orf12SPG43iron accumulationspastic paraplegiaHSP
References
- Hartig MB, Iuso A, Haack T, et al. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet. 2011; 89(4): 543–550.
- Schottmann G, Stenzel W, Lützkendorf S, et al. A novel frameshift mutation of C19ORF12 causes NBIA4 with cerebellar atrophy and manifests with severe peripheral motor axonal neuropathy. Clin Genet. 2014; 85(3): 290–292.
- Deschauer M, Gaul C, Behrmann C, et al. C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. J Neurol. 2012; 259(11): 2434–2439.
- Olgiati S, Doğu O, Tufekcioglu Z, et al. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism Relat Disord. 2017; 39: 64–70.
- Hogarth P, Gregory A, Kruer MC, et al. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology. 2013; 80(3): 268–275.
- Dogu O, Krebs CE, Kaleagasi H, et al. Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. Clin Genet. 2013; 84(4): 350–355.
- Horvath R, Holinski-Feder E, Neeve VCM, et al. A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy. Mov Disord. 2012; 27(6): 789–793.
- Skowronska M, Kmiec T, Kurkowska-Jastrzębska I, et al. Eye of the tiger sign in a 23 year patient with mitochondrial membrane protein associated neurodegeneration. J Neurol Sci. 2015; 352(1-2): 110–111.
- Akcakaya NH, Iseri SU, Bilir B, et al. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey. Clin Neurol Neurosurg. 2017; 154: 34–42.
- Tschentscher A, Dekomien G, Ross S, et al. Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation. J Neurol Sci. 2015; 349(1-2): 105–109.
- Illingworth MA, Meyer E, Chong WK, et al. PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease. Mol Genet Metab. 2014; 112(2): 183–189.
- Landouré G, Zhu PP, Lourenço CM, et al. NIH Intramural Sequencing Center. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat. 2013; 34(10): 1357–1360.
- Kleffner I, Wessling C, Gess B, et al. Behr syndrome with homozygous C19ORF12 mutation. J Neurol Sci. 2015; 357(1-2): 115–118.
- Venco P, Bonora M, Giorgi C, et al. Mutations of C19orf12, coding for a transmembrane glycine zipper containing mitochondrial protein, cause mis-localization of the protein, inability to respond to oxidative stress and increased mitochondrial Ca²⁺. Front Genet. 2015; 6: 185.
